Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Value of Glycated Albumin in Intervention of Glycemic Control in Patients With Type 2 Diabetes: A Multicenter, Randomized Controlled Clinical Study

NCT05227677 is registered in ClinicalTrials.gov with Asahi Kasei Therapeutics Corporation as lead sponsor.

NCT NCT05227677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05227677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Value of Glycated Albumin in Intervention of Glycemic Control in Patients With Type 2 Diabetes: A Multicenter, Randomized Controlled Clinical Study
Lead sponsor
Asahi Kasei Therapeutics Corporation
Phase
Not applicable
Overall status
Completed
Start date
August 15, 2022
Completion date
December 31, 2024
Enrollment
200 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus